儿童急性细菌性颅内感染合并脑静脉窦血栓的队列研究
BACKGROUND AND OBJECTIVES: The epidemiology and optimal treatment strategy of cerebral sinovenous thrombosis (CSVT) in children with acute bacterial intracranial infection is largely unknown.…
要点
- 急性细菌性颅内感染患儿中CSVT患病率高达31%,临床表现无特异性。
- 乳突炎、脑炎、轴外局灶性化脓感染和脱水独立增加CSVT风险。
- 抗凝治疗在该队列中耐受良好,无大出血事件,血栓均有部分溶解。
核心结论
- CSVT在急性细菌性颅内感染患儿中常见但临床难以识别,对高危患儿应保持高度怀疑并考虑筛查影像。
研究设计与样本
- 回顾性观察性队列研究,纳入2015年1月1日至2023年3月31日在一家三级儿童医院住院的1-18岁急性细菌性颅内感染患儿,共108例,中位年龄10岁,41%为女性。
主要发现
- 108例患儿中33例(31%)发生CSVT,CSVT患病率未随年份变化,但急性细菌性颅内感染住院绝对数在研究期间上升,尤其2020年后。
- 发生与未发生CSVT的患儿就诊时神经系统症状体征无差异。
- 乳突炎(aOR 12.2,95%CI 3.1-48.5)、脑炎(aOR 4.6,95%CI 1.5-14.5)、轴外局灶性化脓感染(aOR 10.2,95%CI 1.7-61.6)和脱水(aOR 3.9,95%CI 1.0-15.1)分别与CSVT独立相关。
- 所有CSVT患儿血栓至少部分溶解,60%(20/33)完全溶解。
关键数值与推荐
- CSVT独立危险因素包括乳突炎、脑炎、轴外局灶性化脓感染和脱水。
- CSVT患儿抗凝治疗中位疗程91天,无大出血事件。
临床怎么用
- 对急性细菌性颅内感染患儿,尤其合并乳突炎、脑炎、轴外局灶性化脓感染或脱水者,应高度怀疑CSVT并考虑适当影像学筛查。
- 抗凝治疗在该队列中耐受良好,可考虑用于感染相关CSVT,但需进一步研究确定其安全性、获益和理想疗程。
局限性
- 单中心回顾性研究,样本量有限,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The epidemiology and optimal treatment strategy of cerebral sinovenous thrombosis (CSVT) in children with acute bacterial intracranial infection is largely unknown. We aimed to define the prevalence of CSVT among children with acute bacterial intracranial infection at a tertiary care pediatric hospital, to identify risk factors associated with the development of CSVT in this population, and to describe the use of anticoagulation in these children at our institution. METHODS: This was a retrospective observational cohort study of children aged 1-18 years hospitalized at a tertiary care children's hospital for acute bacterial intracranial infection between January 1, 2015, and March 31, 2023. Children with bacterial meningitis/meningoencephalitis, cerebritis, intraparenchymal abscess, subdural empyema, and/or epidural abscess who had at least 1 head imaging study were included. Cases were identified using ICD codes; medical charts were manually screened to confirm diagnoses. A multivariable logistic regression model was built to identify independent risk factors for the primary outcome of CSVT using the least absolute shrinkage and selection operator technique. RESULTS: Of 108 patients included (median age 10 years, 41% female), 33 (31%) developed CSVT. The prevalence of CSVT did not vary by year, but the absolute number of hospitalizations for acute bacterial intracranial infection rose during the study period, particularly after 2020. Presenting neurologic signs/symptoms did not differ between those who did and did not develop CSVT. Mastoiditis (adjusted odds ratio [aOR] 12.2, 95% CI 3.1-48.5), cerebritis (aOR 4.6, 95% CI 1.5-14.5), extra-axial focal suppurative infection (aOR 10.2, 95% CI 1.7-61.6), and dehydration (aOR 3.9, 95% CI 1.0-15.1) were each independently associated with CSVT. Seventy-three percent of children with CSVT (24/33) received anticoagulation (median duration 91 days) with no major bleeding events. All children with CSVT had at least partial thrombus resolution; 60% (20/33) had complete resolution. DISCUSSION: CSVT is common in children with acute bacterial intracranial infection but difficult to clinically identify. Clinicians should maintain a high index of suspicion for CSVT in this population and consider appropriate screening imaging studies, particularly in children with mastoiditis, cerebritis, extra-axial focal suppurative infection, and/or dehydration. Anticoagulation was well-tolerated in this cohort; further studies should focus on determining its safety, benefit, and ideal duration in infection-related CSVT.
引用
- Mehta N, Sheth N, Halverson M, et al. Cerebral Sinovenous Thrombosis in Children With Acute Bacterial Intracranial Infection. Neurology. 2025. PMID: 41021871. doi:10.1212/WNL.0000000000214175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。